Re: Ultra-Hypofractionated versus Conventionally Fractionated Radiotherapy for Prostate Cancer: 5-Year Outcomes of the HYPO-RT-PC Randomised, Non-Inferiority, Phase 3 Trial

Samir S. Taneja

doi:10.1097/01.JU.0000611500.33954.d2

Re: Ultra-Hypofractionated versus Conventionally Fractionated Radiotherapy for Prostate Cancer: 5-Year Outcomes of the HYPO-RT-PC Randomised, Non-Inferiority, Phase 3 Trial

Samir S. Taneja

Biomedical Engineering

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Number of pages	1
Journal	The Journal of urology
Volume	203
Issue number	1
DOIs	https://doi.org/10.1097/01.JU.0000611500.33954.d2
State	Published - Jan 1 2020

ASJC Scopus subject areas

Urology

Access to Document

10.1097/01.JU.0000611500.33954.d2

Cite this

@article{e6a646d4a52241d29ab132e5f4513a19,

title = "Re: Ultra-Hypofractionated versus Conventionally Fractionated Radiotherapy for Prostate Cancer: 5-Year Outcomes of the HYPO-RT-PC Randomised, Non-Inferiority, Phase 3 Trial",

author = "Taneja, {Samir S.}",

year = "2020",

month = jan,

day = "1",

doi = "10.1097/01.JU.0000611500.33954.d2",

language = "English (US)",

volume = "203",

journal = "The Journal of urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Re

T2 - Ultra-Hypofractionated versus Conventionally Fractionated Radiotherapy for Prostate Cancer: 5-Year Outcomes of the HYPO-RT-PC Randomised, Non-Inferiority, Phase 3 Trial

AU - Taneja, Samir S.

PY - 2020/1/1

Y1 - 2020/1/1

UR - http://www.scopus.com/inward/record.url?scp=85076326704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076326704&partnerID=8YFLogxK

U2 - 10.1097/01.JU.0000611500.33954.d2

DO - 10.1097/01.JU.0000611500.33954.d2

M3 - Comment/debate

C2 - 31634072

AN - SCOPUS:85076326704

SN - 0022-5347

VL - 203

JO - The Journal of urology

JF - The Journal of urology

IS - 1

ER -

Re: Ultra-Hypofractionated versus Conventionally Fractionated Radiotherapy for Prostate Cancer: 5-Year Outcomes of the HYPO-RT-PC Randomised, Non-Inferiority, Phase 3 Trial

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this